Skip to main content

Table 2 Contingency table chi-square test of the factors associated with the use of lenvatinib

From: How the National Health Insurance Coverage policy changed the use of lenvatinib for adult patients with advanced hepatocellular carcinoma: a retrospective cohort analysis with real world big data

Patient characteristics

Number (%)

χ 2

P

Unused

Used

Gender

Male

8656 (88.30)

1147 (11.70)

18.622

0.001

Female

2604 (91.18)

252 (8.82)

Age

≥ 18, < 35

176 (83.81)

34 (16.19)

15.598

0.004

≥ 35, < 50

1519 (87.55)

216 (12.45)

≥ 50, < 65

5364 (88.71)

683 (11.29)

≥ 65, < 80

3776 (89.88)

425 (10.12)

≥ 80

425 (91.20)

41 (8.80)

Type of insurance system

UEBMI

1916 (85.57)

323 (14.43)

64.378

<0.001

URRBMI

6463 (90.87)

649 (9.13)

Uninsured

2881 (87.09)

427 (12.91)

Occupation

Peasants

3759 (89.54)

439 (10.46)

36.552

<0.001

Administrative clerk

871 (83.83)

168 (16.17)

Staff without fixed jobs

2547 (89.62)

295 (10.38)

Retiree

1064 (87.28)

155 (12.72)

Freeman

3019 (89.82)

342 (10.18)

Location of residence

Urban

7332 (88.57)

946 (11.43)

3.448

0.063

Rural

3928 (89.66)

453 (10.34)

Division of provinces and cities

Nanjing area

6389 (89.62)

740 (10.38)

10.756

0.005

Other areas of Jiangsu Province except Nanjing area

3203 (87.54)

456 (12.46)

Outside of Jiangsu Province

1668 (89.15)

203 (10.85)

Hospital level

The tertiary and above hospital

11,009 (88.78)

1392 (11.22)

18.628

<0.001

Below the tertiary level

251 (97.29)

7 (2.71)

Implementation of the NHIC policy

Before

5520 (93.81)

364 (6.19)

264.728

<0.001

After

5740 (84.72)

1035 (15.28)